Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plasma-Cell Myeloma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT05855122
What this trial is testing

Safety and ASCT-related Symptom Burden Optimization of Tocilizumab in ASCT Following HD Melphalan Conditioning for Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
The First Affiliated Hospital of Soochow University 48
Not applicableAvailableNCT03123029
What this trial is testing

Expanded Access to Venetoclax

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)Multiple MyelomaAcute Myeloid Leukemia (AML)+4 more
AbbVie
Testing effectiveness (Phase 2)Ended earlyNCT05288062
What this trial is testing

Immunomodulatory Drugs (Lenalidomide With or Without Pomalidomide) in Combination With a Corticosteroid Drug (Dexamethasone) for the Treatment of Multiple Myeloma

Who this might be right for
Multiple MyelomaRecurrent Multiple MyelomaRefractory Multiple Myeloma+1 more
Mayo Clinic 17
Testing effectiveness (Phase 2)Study completedNCT00229203
What this trial is testing

Aplidin (Plitidepsin) 3 h iv in Subjects With Relapsing or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
PharmaMar 51
Testing effectiveness (Phase 2)Active Not RecruitingNCT04635189
What this trial is testing

Steroid Sparing Treatment With in Newly Diagnosed Transplant Ineligible Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Rochester 28
Not applicableEnrolling By InvitationNCT04210791
What this trial is testing

Autologous Stem Cell Transplantation for Patients With AL Amyloidosis

Who this might be right for
AL AmyloidosisPlasma Cell Dyscrasia
Nanjing University School of Medicine 500
Testing effectiveness (Phase 2)Study completedNCT00833560
What this trial is testing

Bortezomib, Cyclophosphamide, and Dexamethasone in Patients With Untreated Multiple Myeloma and Planned for a High Dose Chemotherapy

Who this might be right for
Multiple Myeloma
Janssen-Cilag G.m.b.H 401
Early research (Phase 1)Looking for participantsNCT05652335
What this trial is testing

JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis

Who this might be right for
Relapsed or Refractory Multiple MyelomaPreviously Treated Amyloid Light-chain (AL) Amyloidosis
Janssen Research & Development, LLC 180
Not applicableActive Not RecruitingNCT00935090
What this trial is testing

3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+6 more
Barbara Ann Karmanos Cancer Institute
Not applicableStudy completedNCT00569868
What this trial is testing

UARK 2005-05, Coagulation-Related Effects of Velcade Treatment in Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
MULTIPLE MYELOMA
University of Arkansas 11
Testing effectiveness (Phase 2)Study completedNCT02057640
What this trial is testing

MLN9708 (Ixazomib) in Combination With Panobinostat and Dexamethasone in Multiple Myeloma

Who this might be right for
Multiple MyelomaKahler DiseasePlasma-Cell Myeloma+1 more
Jason Valent 16
Testing effectiveness (Phase 2)Study completedNCT00078858
What this trial is testing

Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+132 more
Fred Hutchinson Cancer Center 37
Not applicableUnknownNCT02184897
What this trial is testing

Pharmacokinetic and Pharmacodynamic Study of Lenograstim for Hematopoietic Stem Cell Mobilization

Who this might be right for
Multiple Myeloma
Asan Medical Center 24
Testing effectiveness (Phase 2)Study completedNCT00049374
What this trial is testing

Oblimersen, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
University of Maryland, Baltimore
Not applicableStudy completedNCT02955043
What this trial is testing

Biobehavioral Intervention to Enhance Hematopoietic Stem Cell Transplant Recovery

Who this might be right for
Hodgkin LymphomaNon-Hodgkin LymphomaPlasma Cell Myeloma+4 more
University of Wisconsin, Madison 39
Large-scale testing (Phase 3)UnknownNCT02336386
What this trial is testing

CDD Plus Bortezomib or CDDin Relapsed or Refractory Multiple Myeloma With Extramedullary Plasmacytoma

Who this might be right for
Extramedullary Plasmacytoma
Beijing Chao Yang Hospital 100
Not applicableLooking for participantsNCT05974150
What this trial is testing

Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring

Who this might be right for
Breast CancerLung CancerMultiple Myeloma+2 more
Carevive Systems, Inc. 25
Post-approval studies (Phase 4)Not Yet RecruitingNCT07191379
What this trial is testing

Self-administered Subcutaneous Daratumumab in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma in Relapse
Odense University Hospital 50
Not applicableLooking for participantsNCT07642362
What this trial is testing

Digital Support for Multiple Myeloma Quality of Life

Who this might be right for
Multiple MyelomaPatient Reported Outcome (PRO)Supportive Care in Cancer+1 more
CareAcross 108
Not applicableStudy completedNCT05517213
What this trial is testing

High-dose Chemotherapy+G-CSF in Peripheral Blood Stem Cell Mobilization in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Affiliated Hospital to Academy of Military Medical Sciences 62
Next Page